Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines

被引:44
作者
Noda, M
Tatsumi, Y
Tomizawa, M
Takama, T
Mitsufuji, S
Sugihara, H
Kashima, K
Hattori, T
机构
[1] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kamigyo Ku, Kyoto 6028566, Japan
[2] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga, Japan
关键词
cyclooxygenase-2; E-cadherin; catenins; cell proliferation; gastrointestinal carcinoma;
D O I
10.1007/s005350200151
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Recent studies have shown that cyclooxygenase-2 (COX-2) inhibitors may participate in the proliferation of cancer cells. Because the cadherin-catenin complex is not only a key component of the adherens junction but also has been suggested to regulate cell proliferation, modulation of these molecules may be a mechanism by which COX-2 activity affects cell proliferation. In this study, we evaluated the effect of a COX-2 inhibitor on the proliferation and expression of E-cadherin-complexes in gastrointestinal cancer cell lines. Methods. The gastrointestinal cancer cell lines Caco2, HT29, and MKN45 were grown for 24h in the presence and absence of a selective COX-2 inhibitor, etodolac (10(-5), 10(-4), and 10(-3) M). Cell proliferation was assessed by H-3-thymidine incorporation, and the expression of E-cadherin and catenins was assessed by Western blotting, Northern blotting, and immunofluorescence. Results. Etodolac induced a significant reduction in cell proliferation in Caco2 and MKN45 cells. E-cadherin expression was upregulated after stimulation with etodolac in Caco2 cells, whereas the expression of alpha-, beta-, gamma- and p120-catenins was not modified. The expression of E-cadherin mRNA was also upregulated in Caco2 cells, and was upregulated also in MKN45 cells, which did not express normal E-cadherin protein by the use of a mouse monoclonal antibody against human E-cadherin, HECD-1 antibody. Immunofluorescence revealed that the increased E-cadherin was localized at the cytoplasmic membrane. Conclusions. The inhibition of cell growth by etodolac in Caco-2 cells was associated with a dose-dependent upregulation and intense cytoplasmic localization of E-cadherin. No quantitative change in catenin expression was found in this phenomenon. These findings suggest that the COX-2 inhibitor affects the transcription of E-cadherin, or that there may be some homeostatic link between the cell cycle and E-cadherin transcription.
引用
收藏
页码:896 / 904
页数:9
相关论文
共 62 条
  • [1] Bamba H, 1999, INT J CANCER, V83, P470, DOI 10.1002/(SICI)1097-0215(19991112)83:4<470::AID-IJC6>3.3.CO
  • [2] 2-6
  • [3] Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
    Chan, TA
    Morin, PJ
    Vogelstein, B
    Kinzler, KW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 681 - 686
  • [4] Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
    Chapple, KS
    Cartwright, EJ
    Hawcroft, G
    Tisbury, A
    Bonifer, C
    Scott, N
    Windsor, ACJ
    Guillou, PJ
    Markham, AF
    Coletta, PL
    Hull, MA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02) : 545 - 553
  • [5] Chinery R, 1999, CANCER RES, V59, P2739
  • [6] DuBois RN, 1996, CANCER RES, V56, P733
  • [7] UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS
    EBERHART, CE
    COFFEY, RJ
    RADHIKA, A
    GIARDIELLO, FM
    FERRENBACH, S
    DUBOIS, RN
    [J]. GASTROENTEROLOGY, 1994, 107 (04) : 1183 - 1188
  • [8] Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells
    Efstathiou, JA
    Noda, M
    Rowan, A
    Dixon, C
    Chinery, R
    Jawhari, A
    Hattori, T
    Wright, NA
    Bodmer, WF
    Pignatelli, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) : 3122 - 3127
  • [9] Elder DJE, 2000, INT J CANCER, V86, P553, DOI 10.1002/(SICI)1097-0215(20000515)86:4<553::AID-IJC18>3.0.CO
  • [10] 2-9